A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Clinical trial NCT05421299 · COMPLETED
Trial details
- NCT number
- NCT05421299
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-16
- Primary completion
- 2021-02-15
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.